2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$16.80+$0.04 (+0.24%)
Price as of Oct 02, 2026 7:59 PM EDT- $13.3BMarket Cap
- -21.82%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$16.80+$0.04 (+0.24%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.75 | ||
Change | +$0.06 (+0.39%) | ||
Open | $16.96 | ||
High | $17.32 | ||
Low | $16.66 | ||
Previous Close | $16.69 | ||
Volume | 5,196,190 | ||
30-Day Average Volume | 7,599,159 | ||
1-Week Change | 7.34% | ||
1-Month Change | 14.76% | ||
1-Year Change | -21.82% | ||
3-Year Change | 846.61% | ||
5-Year Change | 227.89% | ||
Fundamentals | |||
Shares Outstanding | 797.7M | ||
Total Assets | $752.2M | ||
Market Cap | $13.3B | ||
Enterprise Value | $12.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$215.7M | ||
Free Cash Flow | -$142.0M | ||
EBIT | -$215.7M | ||
EBITDA | -$215.7M | ||
Net Working Capital | $617.0M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -60 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 21 | ||
P/E | -60 | ||
PEG | 4 | ||
Price/Free Cash Flow | -94 | ||
Price/Operating Cash Flow | -94 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue